GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » FCF Margin %

Notable Labs (Notable Labs) FCF Margin % : -4,445.48% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Notable Labs's Free Cash Flow for the six months ended in Dec. 2023 was $-13.78 Mil. Notable Labs's Revenue for the six months ended in Dec. 2023 was $0.31 Mil. Therefore, Notable Labs's FCF Margin % for the quarter that ended in Dec. 2023 was -4,445.48%.

As of today, Notable Labs's current FCF Yield % is -122.25%.

The historical rank and industry rank for Notable Labs's FCF Margin % or its related term are showing as below:

NTBL' s FCF Margin % Range Over the Past 10 Years
Min: -146037.5   Med: -5436.49   Max: -4445.48
Current: -4445.48

During the past 3 years, the highest FCF Margin % of Notable Labs was -4445.48%. The lowest was -146037.50%. And the median was -5436.49%.

NTBL's FCF Margin % is ranked worse than
87.31% of 1040 companies
in the Biotechnology industry
Industry Median: -141.08 vs NTBL: -4445.48

Notable Labs FCF Margin % Historical Data

The historical data trend for Notable Labs's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs FCF Margin % Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
FCF Margin %
-5,436.49 -146,037.50 -4,445.48

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
FCF Margin % -5,436.49 -146,037.50 -4,445.48

Competitive Comparison of Notable Labs's FCF Margin %

For the Biotechnology subindustry, Notable Labs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Notable Labs's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Notable Labs's FCF Margin % falls into.


Notable Labs FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Notable Labs's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-13.781/0.31
=-4,445.48 %

Notable Labs's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-13.781/0.31
=-4,445.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Notable Labs FCF Margin % Related Terms

Thank you for viewing the detailed overview of Notable Labs's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs (Notable Labs) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » FCF Margin %
Comparable Companies
NLSP ACST AGE CRBP NBIO CLRB AIM PLUR BIXT SNSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Website
https://notablelabs.com
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.